argenx launches tender offer for Forte Biosciences at $77 a share

Reuters2026/08/06 11:52

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

argenx launched a cash tender offer for all outstanding Forte Biosciences shares at USD 77 per share.
Offer follows a July 26, 2026 merger agreement between the companies.
Tender offer set to expire Aug. 26, 2026 at 11:59 p.m. ET, unless extended or terminated earlier.
Closing conditions include majority of shares tendered, measured as more than 50% of shares outstanding.
Deal not subject to a financing condition; a second-step merger would make Forte a wholly owned argenx unit.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. arGEN-X SE published the original content used to generate this news brief on August 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

argenx launches tender offer for Forte Biosciences at $77 a share

You may also like

Crypto prices